Preventing nausea and vomiting after GI cancer surgery
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with liver, gallbladder, or pancreatic cancer and had surgery (like tumor removal or bile duct stone removal).
- You received the NEPA capsule as part of your treatment.
- You are not pregnant or nursing, and you are willing to use birth control if needed.
- You have not taken anti-nausea or antidepressant drugs in the 48 hours before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This trial tests if adding HRS5580 to standard anti-nausea medicine works better to stop vomiting after surgery. You may qualify if you are at moderate-to-high risk for nausea after general anesthesia.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
This trial tests if giving pantoprazole before surgery can reduce nausea and vomiting after gynecologic procedures. It may help patients who are having gynecologic surgery under general anesthesia.
This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.
This trial tests a medicine called IV NEPA (fosnetupitant/palonosetron) to prevent nausea and vomiting in children who are receiving strong chemotherapy. Patients will receive at least one cycle of chemotherapy that is highly likely to cause these side effects.
Hear when a new General Anesthesia Gastrointestinal Cancer Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.